What is it?
Bronchiectasis (pronounced brong-kee-EK-tuh-sis) is a chronic lung condition in which the airways (the bronchi and bronchioles that carry air in and out of the lungs) become permanently widened, scarred, and thickened. The medical term for this widening is dilation, and once it happens, it cannot be reversed.
Healthy airways are designed to move mucus efficiently out of the lungs. In bronchiectasis, the damaged airway walls lose this ability. Mucus accumulates, bacteria colonise the pooled secretions, and a cycle begins: infection leads to more inflammation, more inflammation leads to more structural damage, and more damage leads to further loss of function.
This cycle is sometimes called the vicious cycle of bronchiectasis, and is the central mechanism that disease management aims to interrupt. The condition is not curable, but it is highly manageable, and the range of outcomes between people who actively manage it and those who don't is significant.
How the airways work
The lungs are not simple bags of air. They're a branching tree of increasingly small tubes. From the trachea, to two main bronchi, branching into smaller bronchi, then bronchioles, and finally into millions of tiny air sacs called alveoli, where gas exchange actually happens.
The inner surface of healthy airways is lined with tiny hair-like structures called cilia, which beat in coordinated waves to move mucus up and out. This is a mechanism called mucociliary clearance. Think of it as a conveyor belt that continuously sweeps debris, pathogens, and excess mucus toward the throat where it can be cleared.
In bronchiectasis, repeated cycles of infection and inflammation damage both the structural walls of the airways and the cilia themselves. The airways dilate and lose their elasticity. Mucus pools in the lower sections of the widened tubes. The conveyor belt slows, creating environments where bacteria thrive and further damage accumulates.
Healthy airway
Narrow, elastic walls. Cilia intact. Mucus clears freely.
Bronchiectatic airway
Dilated, inelastic walls. Cilia damaged. Mucus accumulates.
Symptoms
Symptoms vary considerably between individuals — some people have mild BX that is largely asymptomatic outside of exacerbations; others experience significant daily burden. The most common:
Chronic productive cough
The most consistent symptom. Daily coughing that brings up mucus (sputum), often worse in the mornings. Volume and colour are useful indicators of stability or infection.
Breathlessness
Ranges from exertional only (on hard effort) to present at rest in more advanced cases. Exercise capacity tends to be reduced, though it is trainable.
Chest tightness or wheeze
Caused by narrowed, inflamed airways. May be mistaken for asthma. Can fluctuate with infection or activity level.
Exacerbations
Periods of acute worsening. Usually more sputum, worse breathlessness, fatigue, sometimes fever. Typically triggered by respiratory infections. Frequency varies widely.
Fatigue
Often underestimated. Chronic inflammation, disturbed sleep from coughing, and the physical work of breathing all contribute to persistent tiredness.
Haemoptysis
Coughing up blood. Can range from blood-streaked sputum (common) to larger bleeds (less common). Always worth reporting to your clinical team.
Causes
Bronchiectasis is not a single disease. It is a structural consequence that can result from a wide range of underlying conditions. Identifying the cause matters: it can affect prognosis, treatment options, and whether family members should be screened.
Post-infectious
The most common cause globally. Repeated or severe respiratory infections (including childhood pneumonia, whooping cough, tuberculosis, or non-tuberculous mycobacteria (NTM)) can cause enough airway damage to result in permanent dilation.
Idiopathic
In a significant proportion of cases (estimates vary between 26–53%) no underlying cause is found despite thorough investigation. This is called idiopathic bronchiectasis. It doesn't mean the disease is less real or less treatable.
Primary Ciliary Dyskinesia (PCD)
A genetic condition in which the cilia lining the airways don't function correctly from birth. Without working cilia, mucus clearance fails, leading to chronic infection and progressive airway damage.
Immune deficiencies
Conditions that reduce the body's ability to fight infection (including CVID and other antibody deficiencies) allow recurrent lung infections that gradually cause bronchiectatic damage.
Inflammatory & connective tissue disorders
An association exists between bronchiectasis and conditions including Crohn's disease, ulcerative colitis, and rheumatoid arthritis. The mechanism is not fully understood but may relate to shared inflammatory pathways.
Aspiration
Repeated inhalation of stomach acid or food particles, as can occur with certain swallowing conditions or significant reflux, can damage airway tissue over time.
Diagnosis
Bronchiectasis is diagnosed by High Resolution CT scan (HRCT) of the chest. A plain chest X-ray may show changes but is not sensitive enough for definitive diagnosis. The CT identifies dilated airways, distribution of disease across the lung lobes, and associated structural changes.
Diagnosis often follows a frustratingly long journey. A common pattern is years of "recurrent chest infections" before anyone orders the right scan. Average time from first symptoms to diagnosis is frequently reported as several years.
HRCT chest scan
Confirms presence and distribution of bronchiectasis. The gold standard.
Lung function tests (spirometry)
Measures airflow obstruction and overall lung capacity. Provides a baseline to track over time.
Sputum cultures
Identifies bacteria colonising the airways — critical for guiding antibiotic choices when treatment is needed.
Blood tests & immunology
Screens for immune deficiencies and markers of systemic inflammation.
Investigation for underlying cause
Depending on the clinical picture: sweat test (cystic fibrosis), nasal brushings (PCD), allergy panel (ABPA), and others.
Treatment
There is no cure for bronchiectasis, but the goals of treatment are clear: reduce exacerbations, slow structural decline, control symptoms, and maintain or improve quality of life. Treatment is highly individual.
Airway clearance therapy (ACT)
The cornerstone of daily management. Techniques include Active Cycle of Breathing (ACBT), oscillating PEP devices (Acapella, Flutter), and postural drainage. Most people with BX do this at least once daily, twice on bad days.
Daily practicePulmonary rehabilitation
Structured exercise and education programmes shown to improve exercise tolerance, quality of life, and exacerbation recovery. One of the most evidence-supported interventions in chronic lung disease.
Evidence-strongAntibiotics
Used to treat acute exacerbations (typically 14 days) and in some cases as long-term prophylaxis to reduce exacerbation frequency. Choice depends on sputum culture results.
Reactive & prophylacticInhaled therapies
Bronchodilators (before ACT), hypertonic saline (to thin and mobilise mucus), and occasionally inhaled antibiotics. Not all are appropriate for every patient.
InhaledVaccinations
Annual influenza and pneumococcal vaccines significantly reduce the risk of infections that can trigger exacerbations. COVID-19 vaccination is also recommended.
PreventionSurgery (rare)
In cases where disease is localised to one lobe and causing significant problems despite medical management, surgical resection may be considered. Not appropriate for most people with BX.
Rare cases onlyExercise & BX
This is, in many ways, the core question that BX Ultra exists to answer. The short version: exercise is not just safe for most people with bronchiectasis — it is one of the most powerful interventions available.
Exercise acts as a form of airway clearance: increased breathing rate and depth helps mobilise mucus. Aerobic training improves cardiovascular efficiency, meaning the lungs have to work less to deliver the same oxygen. Strength training supports respiratory muscle function. And the psychological benefits like reduced anxiety and improved sense of agency over the condition are independently valuable.
Practical considerations for training with BX:
- Do airway clearance before training — clearing mucus first means you exercise with cleaner airways and better gas exchange.
- Monitor sputum changes — colour, volume, and consistency during and after exercise can signal an oncoming exacerbation before other symptoms appear.
- Train through stable phases; modify during exacerbations — complete rest is usually not advised during an exacerbation, but intensity should be reduced significantly.
- Zone 2 is your friend — sustained, conversational-pace aerobic work builds the base that makes higher intensities more accessible. Also generally well-tolerated on harder days.
- Work with your respiratory physiotherapist — they can advise on ACT techniques that complement your specific training load.
Living with BX
A bronchiectasis diagnosis changes daily life, but the range of what that change looks like is enormous. Some people have minimal disruption after establishing a management routine. Others face significant daily burden, frequent hospitalisations, and real limitations. Most people sit somewhere between these poles, and where you sit can shift over time.
- Consistent airway clearance, done daily — even when you feel well. Especially when you feel well. Maintaining a clear airway is much easier than clearing a blocked one.
- Understanding your own exacerbation pattern — what triggers them, how they start, how long they last. Pattern recognition is one of the most useful skills to develop.
- Air quality awareness — indoor air quality, outdoor pollution on high-intensity training days, and humidity all affect symptoms. The Lifestyle Hub covers this in detail.
- Sleep — disrupted by coughing in many people with BX. Positional adjustments and pre-sleep ACT can make a significant difference.
- A good specialist — a respiratory physician with bronchiectasis experience, and a respiratory physiotherapist. These two relationships are the most important clinical ones to invest in.